Mode
Text Size
Log in / Sign up

Rett syndrome

Part of X-Linked Intellectual Disability

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Rett syndrome

8 trials tracked for Rett syndrome: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 182 citations.

8Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 2 Phase 2 5 Phase 1 1
  1. Phase 3 Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™) Completed · 182 cited
  2. Phase 3 Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome Completed · 30 cited
  3. Phase 2 Treatment of Rett Syndrome With Recombinant Human IGF-1 Completed
  4. Phase 2 Pharmacological Treatment of Rett Syndrome With Statins Completed
  5. Phase 2 Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone) Completed
  6. Phase 2 A Study to Evaluate Ketamine for the Treatment of Rett Syndrome Completed
Show 2 more trials
  1. Phase 2 Placebo Controlled Trial of Dextromethorphan in Rett Syndrome Completed
  2. Phase 1 Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection) Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Rett syndrome

Does trofinetide treatment show symptom improvement for children with Rett syndrome?

Trofinetide shows symptom improvement in Rett syndrome, with real-world studies showing about 76% of patients experiencing benefits in communication and motor skills.

Full answer →